![]() |
|
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Vol. 304, Issue 3, 931-939, March 2003
Departments of Molecular Pharmacology and Biological Chemistry
(M.J.G., M.I.M., D.R., R.J.M., M.L.D.) and Psychiatry and Behavioral
Sciences (M.L.D.), Northwestern University Institute for Neuroscience
(M.J.G., M.I.M., R.J.M., M.L.D.), Northwestern Drug Discovery Program
(M.J.G., M.I.M., R.J.M., M.L.D.), Feinberg School of Medicine,
Northwestern University, Chicago, Illinois
The hormone melatonin mediates a variety of physiological functions in
mammals through activation of pharmacologically distinct MT1 and MT2 G protein-coupled melatonin
receptors. We therefore sought to investigate how the receptors were
regulated in response to short melatonin exposure. Using
2-[125I]iodomelatonin binding, cAMP functional assays,
and confocal microscopy, we demonstrated robust differences in specific
2-[125I]iodomelatonin binding, receptor desensitization,
and cellular trafficking of hMT1 and hMT2
melatonin receptors expressed in Chinese hamster ovary (CHO) cells
after short (10-min) exposure to melatonin. Exposure to melatonin
decreased specific 2-[125I]iodomelatonin binding to
CHO-MT2 cells (70.3 ± 7.6%, n = 3) compared with vehicle controls. The robust decreases in specific binding to the hMT2 melatonin receptors correlated both
with the observed functional desensitization of melatonin to inhibit
forskolin-stimulated cAMP formation in CHO-MT2 cells
pretreated with 10 nM melatonin (EC50 of 159.8 ± 17.8 nM, n = 3, p < 0.05) versus
vehicle (EC50 of 6.0 ± 1.2 nM, n = 3), and with the arrestin-dependent internalization of the receptor.
In contrast, short exposure of CHO-MT1 cells to melatonin
induced a small decrease in specific
2-[125I]iodomelatonin binding (34.2 ± 13.0%,
n = 5) without either desensitization or receptor
internalization. We conclude that differential regulation of the
hMT1 and hMT2 melatonin receptors by the
hormone melatonin could underlie temporally regulated signal
transduction events mediated by the hormone in vivo.
This article has been cited by other articles:
![]() |
M. J. GERDIN, M. I. MASANA, M. A. RIVERA-BERMUDEZ, R. L. HUDSON, D. J. EARNEST, M. U. GILLETTE, and M. L. DUBOCOVICH Melatonin desensitizes endogenous MT2 melatonin receptors in the rat suprachiasmatic nucleus: relevance for defining the periods of sensitivity of the mammalian circadian clock to melatonin FASEB J, November 1, 2004; 18(14): 1646 - 1656. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. E. Blask, R. T. Dauchy, L. A. Sauer, and J. A. Krause Melatonin uptake and growth prevention in rat hepatoma 7288CTC in response to dietary melatonin: melatonin receptor-mediated inhibition of tumor linoleic acid metabolism to the growth signaling molecule 13-hydroxyoctadecadienoic acid and the potential role of phytomelatonin Carcinogenesis, June 1, 2004; 25(6): 951 - 960. [Abstract] [Full Text] [PDF] |
||||